Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNotes PayablesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Universe Pharmaceuticals (UPC) Intangibles (2020 - 2025)

Universe Pharmaceuticals' Intangibles history spans 4 years, with the latest figure at $473.9 million for Q3 2025.

  • For Q3 2025, Intangibles changed N/A year-over-year to $473.9 million; the TTM value through Sep 2025 reached $473.9 million, changed N/A, while the annual FY2025 figure was $473.9 million, N/A changed from the prior year.
  • Intangibles for Q3 2025 was $473.9 million at Universe Pharmaceuticals, up from $157451.0 in the prior quarter.
  • Across five years, Intangibles topped out at $473.9 million in Q3 2025 and bottomed at $157451.0 in Q3 2022.
  • The 3-year median for Intangibles is $178483.0 (2021), against an average of $158.1 million.
  • The largest annual shift saw Intangibles rose 2.12% in 2021 before it decreased 11.78% in 2022.
  • A 3-year view of Intangibles shows it stood at $178483.0 in 2021, then fell by 11.78% to $157451.0 in 2022, then soared by 300902.22% to $473.9 million in 2025.
  • Per Business Quant, the three most recent readings for UPC's Intangibles are $473.9 million (Q3 2025), $157451.0 (Q3 2022), and $178483.0 (Q3 2021).